Search Results for: angioimmunoblastic T-cell lymphoma

T-Cell Lymphoma: What You Need to Know

Importance of T-Cells in Lymphoma Only about 15% of the total of non-Hodgkin’s lymphomas diagnosed in the United States are T-cell lymphomas. The T-cells have a similar function to a type ... Read more

Types of Lymphoma: What You Need to Know

Lymphoma is a type of cancer that affects the lymphatic system, particularly the white blood cells called lymphocytes that work as protection against infections and diseases. Lymphocytes affected by the disease ... Read more

June 6, 2019

Adcetris Combo Continues to Show Better Results Than Chemotherapy Alone, Phase 3 Update Reveals

News

Seattle Genetics‘ Adcetris (brentuximab vedotin) in combination with standard chemotherapy continues to show better clinical activity than bleomycin plus standard chemotherapy, as a front-line treatment for patients with Hodgkin’s lymphoma, updated ... Read more

November 20, 2018

Adcetris-Chemo Combo Gets FDA Approval for First-line Treatment of PTCL

News

The U.S. Food and Drug Administration (FDA) approved Seattle Genetics‘ application requesting that Adcetris (brentuximab vedotin) be used in combination with chemotherapy as a first-line treatment for systemic anaplastic large cell ... Read more

June 7, 2018

Cerdulatinib Shows Promising Phase 2a Trial Results in Blood Cancer Patients, Including NHL

News

Portola Pharmaceuticals‘ investigative therapy cerdulatinib is effective and well-tolerated in patients with several types of blood cancer, including non-Hodgkin’s lymphoma, who failed multiple prior therapies, according to interim results of ... Read more